University of Birmingham
Factors affecting CD4 T cell recognition of the EBV-encoded tumour antigen EBNA1
Abstract
dc:description.abstractEpstein-Barr virus (EBV) is associated with 200,000 cases of cancer per year. Although these include B cell lymphomas and epithelial carcinomas, the ability of T cells specific to viral antigens to target the latter, which constitute the majority of cases, has not been explored. In this study I have investigated the processing and CD4 T cell recognition of epithelial cells expressing EBNA1, a virally-encoded protein expressed in all EBV-associated malignancies. EBNA1 was equally stable in B cells and epithelial cells but EBNA1-specific CD4 T cell clones were nevertheless able to recognise both types of target cell. The potential effects of EBV-encoded micro-RNA BART18 on autophagy and CD4 T cell recognition were examined and showed that the loss of BART18 increased the autophagy levels of EBV-positive Jijoye Burkitt lymphoma cells under nutrient starvation conditions. Finally, the effects of a pharmacological inhibitor of EBNA1 dimerisation, JLP2, on the viability and T cell recognition of EBV-positive B cells was also investigated. JLP2 did not increase CD4 T cell recognition but transiently decreased the viability of one of two EBV-positive lymphoblastoid cell lines coincident with this line’s uptake of the drug.
Degree
thesis:*- Name dc:type.qualificationname
- m_rs
- Level dc:type.qualificationlevel
- m_rs
- Grantor dc:publisher.institution
- University of Birmingham
- Year dc:date.issued
- 2014
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Leonard, Henry
Subjects
dc:subject × 1Rights
- Language dc:language.dcterms_iso639_2
- eng